Literature DB >> 16005613

Risk for schizophrenia--broadening the concepts, pushing back the boundaries.

Mary Cannon1, Mary Catherine Clarke.   

Abstract

This paper gives an overview of environmental risk factors for schizophrenia. The presence of certain biological and psychosocial factors at certain points in the lifespan has been linked to later development of schizophrenia. These include prenatal infection, obstetric complications, childhood developmental impairments, early rearing environment, adolescent cannabis use, urban dwelling and membership of a minority population. Some of these risk factors operate on an individual level and some on a societal level but all need to be considered in the context of schizophrenia as a life-long brain disorder. Research interest in schizophrenia, especially neuro-imaging interest, is shifting to ever earlier stages of the disease process and so the journey to discover the causes of schizophrenia is likely to take us right back to the beginning of development.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16005613     DOI: 10.1016/j.schres.2005.05.027

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  25 in total

1.  Maladaptive schemas as a mediator between social defeat and positive symptoms in young people at clinical high risk for psychosis.

Authors:  Jacqueline Stowkowy; Jean Addington
Journal:  Early Interv Psychiatry       Date:  2011-09-23       Impact factor: 2.732

Review 2.  The International Society for Developmental Psychobiology annual meeting symposium: Impact of early life experiences on brain and behavioral development.

Authors:  Regina Sullivan; Donald A Wilson; Joram Feldon; Benjamin K Yee; Urs Meyer; Gal Richter-Levin; Avital Avi; Tsoory Michael; Michael Gruss; Jörg Bock; Carina Helmeke; Katharina Braun
Journal:  Dev Psychobiol       Date:  2006-11       Impact factor: 3.038

3.  Is traumatic brain injury a risk factor for schizophrenia? A meta-analysis of case-controlled population-based studies.

Authors:  Charlene Molloy; Ronan M Conroy; David R Cotter; Mary Cannon
Journal:  Schizophr Bull       Date:  2011-08-02       Impact factor: 9.306

Review 4.  Violent behaviour among people with schizophrenia: a framework for investigations of causes, and effective treatment, and prevention.

Authors:  Sheilagh Hodgins
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-08-12       Impact factor: 6.237

5.  Schizophrenia: current concepts and approaches to patient care.

Authors:  Peter F Buckley; Adriana Foster
Journal:  Am Health Drug Benefits       Date:  2008-05

Review 6.  Identifying novel interventional strategies for psychiatric disorders: integrating genomics, 'enviromics' and gene-environment interactions in valid preclinical models.

Authors:  Caitlin E McOmish; Emma L Burrows; Anthony J Hannan
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

7.  The role of vulnerability factors in individuals with an at-risk mental state of psychosis.

Authors:  Martina Papmeyer; Irène Würsch; Erich Studerus; Rolf-Dieter Stieglitz; Anita Riecher-Rössler
Journal:  Neuropsychiatr       Date:  2016-03-11

8.  Etiological and clinical features of childhood psychotic symptoms: results from a birth cohort.

Authors:  Guilherme Polanczyk; Terrie E Moffitt; Louise Arseneault; Mary Cannon; Antony Ambler; Richard S E Keefe; Renate Houts; Candice L Odgers; Avshalom Caspi
Journal:  Arch Gen Psychiatry       Date:  2010-04

Review 9.  Evidence for maternal-fetal genotype incompatibility as a risk factor for schizophrenia.

Authors:  Christina G S Palmer
Journal:  J Biomed Biotechnol       Date:  2010-04-06

10.  Combined effect of neonatal immune activation and mutant DISC1 on phenotypic changes in adulthood.

Authors:  Daisuke Ibi; Taku Nagai; Hiroyuki Koike; Yuko Kitahara; Hiroyuki Mizoguchi; Minae Niwa; Hanna Jaaro-Peled; Atsumi Nitta; Yukio Yoneda; Toshitaka Nabeshima; Akira Sawa; Kiyofumi Yamada
Journal:  Behav Brain Res       Date:  2009-08-28       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.